Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 3, 2023
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
[ Mon, Apr 03rd 2023
] - WOPRAI
Tiago Fauth Downgraded (ASND) to Hold on, Apr 3rd, 2023
Tiago Fauth of Credit Suisse, Downgraded "Ascendis Pharma A/S" (ASND) to Hold on, Apr 3rd, 2023.
Tiago has made no other calls on ASND in the last 4 months.
There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tiago
- Vikram Purohit of "Morgan Stanley" Maintained at Buy with Increased Target to $151 on, Friday, February 17th, 2023
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $163 on, Tuesday, January 17th, 2023
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $177 on, Tuesday, January 3rd, 2023
